Literature DB >> 34035691

Current Management of Alcohol-Associated Liver Disease.

Faisal A Siddiqi1, Krishna C Sajja2, Nyan L Latt3.   

Abstract

Alcohol consumption is a major risk factor for various diseases worldwide and is one of the most common causes of chronic liver disease. Alcohol use has risen over the past 30 years and is forecast to continue to rise. Concurrently, there has been an increased incidence of alcohol-associated liver disease (ALD). Alcohol use, regardless of the amount, leads to years of health loss across populations when considering the strong association between alcohol consumption and overall disease burden. Given the rising incidence of ALD and associated mortality, it is imperative to study the underlying factors driving these trends. This article summarizes the diagnosis and management of ALD, with a focus on various screening and prognostic tools and treatments for alcohol-associated hepatitis.
Copyright © 2020, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Alcohol-associated liver disease; alcohol-associated hepatitis; alcoholic cirrhosis; alcoholic hepatitis; cirrhosis; liver transplantation

Year:  2020        PMID: 34035691      PMCID: PMC8132623     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  53 in total

Review 1.  Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.

Authors:  Anam Khan; Aylin Tansel; Donna L White; Waleed Tallat Kayani; Shah Bano; Jan Lindsay; Hashem B El-Serag; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-06       Impact factor: 11.382

Review 2.  Late evening snack: exploiting a period of anabolic opportunity in cirrhosis.

Authors:  Cynthia D Tsien; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

3.  Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-11-13       Impact factor: 56.272

4.  The high burden of alcoholic cirrhosis in privately insured persons in the United States.

Authors:  Jessica L Mellinger; Kerby Shedden; Gerald Scott Winder; Elliot Tapper; Megan Adams; Robert J Fontana; Michael L Volk; Frederic C Blow; Anna S F Lok
Journal:  Hepatology       Date:  2018-05-20       Impact factor: 17.425

Review 5.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

6.  Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.

Authors:  Jakob Manthey; Kevin D Shield; Margaret Rylett; Omer S M Hasan; Charlotte Probst; Jürgen Rehm
Journal:  Lancet       Date:  2019-05-07       Impact factor: 79.321

7.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

8.  Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States.

Authors:  George Cholankeril; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-01       Impact factor: 11.382

9.  Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States.

Authors:  Raxitkumar Jinjuvadia; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2015-07       Impact factor: 3.062

Review 10.  Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2018-08-23       Impact factor: 202.731

View more
  1 in total

1.  1-O-Actylbritannilactone Ameliorates Alcohol-Induced Hepatotoxicity through Regulation of ROS/Akt/NF-κB-Mediated Apoptosis and Inflammation.

Authors:  Li-Ya Xie; Zhen Yang; Ying Wang; Jun-Nan Hu; Ya-Wei Lu; Hao Zhang; Shuang Jiang; Wei Li
Journal:  ACS Omega       Date:  2022-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.